Hedera (HBAR) and Injective Protocol (INJ) backers spot a golden opportunity in Kelexo's (KLXO) presale, eyeing 20X gains amid market turbulence The post Hedera (HBAR) and Injective Protocol (INJ) Investors See 20X Potential in Kelexo’s (KLXO) Presale Amid Cryptocurrency Turbulence appeared first on Latest News and Insights on Blockchain, Cryptocurrency, and Investing .
